EMA publishes QPPV Update
Recommendation
25/26 February 2026
Definition, Manufacture, Assessment and Handling post approval Changes
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In April 2016 the European Medicines Agency (EMA) published the first issue of the quarterly issued "QPPV Update - What´s new in Pharmacovigilance". The "QPPV Update" replaces the "Pharmacovigilance Programme Update" which focused on information systems and services.
The new newsletter contains general information regarding pharmacovigilance and provides Qualified Persons responsible for Pharmacovigilance (QPPVs) and all other people working in pharmacovigilance with an update on EU pharmacovigilance.
The first issue of the "QPPV Update" covers the following topics:
- Pharmacovigilance in the product lifecycle,
- Pharmacovigilance processes,
- Pharmacovigilance guidance,
- Pharmacovigilance IT systems,
- Pharmacovigilance dialogue.
Qualified Persons for Pharmacovigilance (QPPVs) who are registered in the XEVMPD database according to Article 57 of Regulation (EG) No 726/2004 receive this document directly via EudraLink. You can find the Newsletter on the website of the EMA.
Related GMP News
10.12.2025Guideline for CEP Revisions published for Comment
10.12.2025Revised Q&As for Centralised Procedures - Post-authorisation
09.12.2025Updated Q&As for Centralised Procedures - pre-authorisation procedural advice
01.10.2025Updated Classification Guideline Published
16.09.2025EMA updates IRIS Documents
16.09.2025eSubmission: Update to the 'PLM Portal eAF - Release Notes'